Tomasz Kostrzewski has been appointed chief scientific officer at CN Bio Innovations Ltd, an organ-on-a-chip company in the UK. This is his third promotion since joining the company in 2015. Previously he worked at Imperial College London studying immune cell development and stem cell differentiation. He also worked at GSK Plc in drug discovery and development. At CN Bio he currently leads a collaboration with the US Food and Drug Administration which is examining how organ-on-chips can improve preclinical estimates of the bioavailability of drugs compared with standard animal models.
CN Bio announced the promotion on 30 August 2023.
Copyright 2023 Evernow Publishing Ltd.